Share: Facebook Twitter LinkedIn
Activity Provided By:

Integritas Communications

Diagnosis and Management of Patients With Predominant Skin Symptoms

Access Activity

Overview / Abstract:

The educational design of this activity addresses the needs of allergy/clinical immunology, gastroenterology, dermatology, and hematology clinicians who manage patients with nonadvanced systemic mastocytosis.

Nonadvanced systemic mastocytosis (SM) is a group of rare disorders characterized by mast cell accumulation that results in a significant and varied symptomatic burden to the patient. The most prevalent of these symptoms include gastrointestinal symptoms, dermatological symptoms, and recurrent anaphylaxis in response to a variety of triggers such as food, insect venom, and medications. In this Phone-a-Friend series, a multidisciplinary panel of faculty experts will address the importance of high-sensitivity assays to detect the KIT D816V mutation that is responsible for most cases of nonadvanced SM, the recently updated World Health Organization diagnostic criteria, the various triggers of mast cell activation, symptom assessment techniques, and patient education. The faculty will also discuss individualization of symptom-directed treatment strategies, evolving treatment options, and newly approved targeted therapies for the treatment of nonadvanced SM.


Jun 21, 2024


Nurse Practitioner , Physician Assistant CME, Respiratory Therapy CE


Online, Webinar / Webcast / Video

Credits / Hours




Presenters / Authors / Faculty

Anthony P. Fernandez, MD, PhD
Assistant Professor of Clinical Medicine, CCLCM
Director of Medical Dermatology
W.D. Steck Chair of Clinical Dermatology
Cleveland Clinic
Cleveland, Ohio
Matthew P. Giannetti, MD
Instructor, Harvard Medical School
Allergy and Immunology
Associate Director
Brigham and Women’s Hospital Mastocytosis Center
Boston, Massachusetts

Sponsors / Supporters / Grant Providers

This activity is jointly provided by Global Education Group and Integritas Communications. (AANP Credit)

This activity is supported by an independent educational grant from Blueprint Medicines Corporation.

Keywords / Search Terms

Integritas Communications SM, systemic mastocytosis, AANP, ACCME Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map